NUR 509 Exam 1 questions with correct answers

NUR 509 Exam 1 questions with correct answers
|\ |\ |\ |\ |\ |\ |\




1.Adverse Reaction: Undesirable drug effects, severe and life threatening.
|\ |\ |\ |\ |\ |\ |\ |\




2.Side Effects: Undesirable drug effect, is a mild reaction.
|\ |\ |\ |\ |\ |\ |\ |\




3.First Pass: Ingest the drug orally, metabolized (usually by the liver or
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




gut), the effect of the medication is reduced, and only part of the drug
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




reaches the systemic circulation. The drugs will end up becoming less
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




powerful.
4.first pass routes: Hepatic
|\ |\ |\ |\




arterial Oral/entral |\




Portal venous |\




5.Half-Life: Time required for the body to eliminate 50% of a drug
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




6.Approximately how many half lives does it take to remove a drug from the |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




body?: About 5 half-lives |\ |\ |\




7.Off Label Drugs: Drug is FDA approved for one use, but is being
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




prescribed for a different purpose. |\ |\ |\ |\




8.FDA Approved Drugs: approved for a specific purpose
|\ |\ |\ |\ |\ |\ |\




9.Sublingual Route of Administration: absorbed more rapidly than enteric-
|\ |\ |\ |\ |\ |\ |\ |\




coat- ed tablets. Sublingual medications are placed under the tongue
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\




and dissolve, allowing for quick absorption through the mucous
|\ |\ |\ |\ |\ |\ |\ |\ |\




membranes and entry into the bloodstream. |\ |\ |\ |\ |\




Bypass first-pass effect |\ |\




10.Enteral Route of Administration: enteric-coated tablets have a coating
|\ |\ |\ |\ |\ |\ |\ |\



1 |\/ |\23

,|\ that prevents them from being broken down in the acidic environment
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




of the stomach. They are not absorbed until they reach the higher pH of
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




|\ the intestines, resulting in slower absorption.
|\ |\ |\ |\ |\




11.Intravenous Route of Administration: Medication administered via the |\ |\ |\ |\ |\ |\ |\ |\




veins, produces the most rapid drug response , can produce an almost
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




immediate onset of action (bypasses the first past effect)
|\ |\ |\ |\ |\ |\ |\ |\




12.Intramuscular Route of Administration: Requires a needle for |\ |\ |\ |\ |\ |\ |\ |




administration, medication is administered in the muscle, allows drug to |\ |\ |\ |\ |\ |\ |\ |\ |\ |




diffuse slowly into the many blood vessels within muscle tissue
|\ |\ |\ |\ |\ |\ |\ |\ |\ |




(bypasses the first pass effect). |\ |\ |\ |\




13.Subcutaneous Route of Administration: Medication administered under |\ |\ |\ |\ |\ |\




|\ the skin into the SUBCUTANEOUS tissue (bypasses the first pass effect)
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\




14.Intradermal Route of Administration: Medication is administered into |\ |\ |\ |\ |\ |\ |\




|\ the DERMIS of the skin (bypasses the first pass effect).
|\ |\ |\ |\ |\ |\ |\ |\ |\




15.Buccal Route of Administration: Medication is administered in the
|\ |\ |\ |\ |\ |\ |\ |\ |\




oral mu- cosa between the cheek and gum (bypasses first pass effect)
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




16.Rectal Route of Administration: The delivery of medication via the
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\




rectum, good alternative when oral is not available (does NOT bypass
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




first pass effect)
|\ |\




2 |\/ |\23

, 17.Topical Route of Administration: Medication is applied directly on the |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




skin via ointment, gels, or creams (bypasses the first pass effect)
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\




18.Transdermal Route of Administration: Medication is administered via |\ |\ |\ |\ |\ |\ |\ |\




adhe- sive patches, provide constant rate of absorption (bypasses first
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\




pass effect) |\




19.Inhalation Route of Administration: Medication is directly delivered |\ |\ |\ |\ |\ |\ |\ |\




to the lungs for rapid absorption (bypasses first pass effect)
|\ |\ |\ |\ |\ |\ |\ |\ |\




20.potential for abuse or addiction |\ |\ |\ |\ |\




Schedule I Drug |\ |\




schedule 2 |\




schedule 3 |\




schedule 4 |\




schedule 5: 1: very high risk (not considered legitimate medical use):
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




heroin, LSD, Marijuana |\ |\




2: high risk (have a strong potential for abuse or addiction but also have
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




legitimate medical use): opium, morphine, cocaine |\ |\ |\ |\ |\




3: moderate risk (have less potential for abuse or addiction than
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




schedule I or II drugs and have a useful medication purpose): Short-
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




acting barbiturates and amphetamines |\ |\ |\




4: low risk: (a medically useful category of drugs that have less potential
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




for abuse or addiction than those of Schedules I, II, and III): diazepam
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




and chloral hydrate |\ |\




5: very low risk: (medically useful category of drugs that have less
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\




potential for abuse or addiction than those of Schedules I through IV):
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\



3 |\/ |\23